Mr Pierre Leo Robitaille, RPH | |
6 Loudon Road, Suite 3, Concord, HI 03301 | |
(603) 230-1111 | |
(603) 227-7500 |
Full Name | Mr Pierre Leo Robitaille |
---|---|
Gender | Male |
Speciality | Pharmacist |
Location | 6 Loudon Road, Concord, Hawaii |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1689895443 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 1658 (New Hampshire) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Pierre Leo Robitaille, RPH 36 Donna Avenue, Manchester, NH 03103-3922 Ph: (603) 622-1471 | Mr Pierre Leo Robitaille, RPH 6 Loudon Road, Suite 3, Concord, HI 03301 Ph: (603) 230-1111 |
News Archive
In this age of highly realistic computer games and increasingly popular social networks, social exclusion in virtual worlds is becoming more and more socially significant, as is demonstrated by the growing number of "cyber mobbing" cases.
OptMed Inc., a medical device manufacturer, announced today that the Company received 510(k) marketing clearance from the US Food and Drug Administration for its BondEase product, a topical skin adhesive intended for the closure of surgical incisions and lacerations as an alternative to sutures and staples.
GE Healthcare has today launched its third annual #GetFit global public awareness campaign on cancer prevention. This year's campaign leverages social media channels including Instagram, Sina Weibo in China, and Twitter to enable participation, interaction and engagement.
When young mice with the rodent equivalent of a rare autism spectrum disorder (ASD), called Rett syndrome, were fed a diet supplemented with the synthetic oil triheptanoin, they lived longer than mice on regular diets. Importantly, their physical and behavioral symptoms were also less severe after being on the diet, according to results of new research from The Johns Hopkins University.
The Chemical Alliance Zone's Chemicals and Materials Commercialization Fund has awarded $20,000 to a Marshall University scientist to help bring to market a technology he has developed for repairing skin injuries.
› Verified 3 days ago